GSK China announced on July 18, 2016, that Cervarix (HPV vaccine 16 and 18) had been approved by China Food and Drug Administration (CFDA), therefore became the first approved HPV vaccine in China.
2016年7月18日葛兰素史克中国宣布疫苗Cervarix（HPV疫苗16和18）已获得中国食品药品监督管理局（CFDA）的批准，因此成为中国第一个获得批准的HPV疫苗。